News Image

Based on good technical signals, IONIS PHARMACEUTICALS INC is potentially setting up for a breakout.

By Mill Chart

Last update: Dec 19, 2023

A possible breakout setup was detected on IONIS PHARMACEUTICALS INC (NASDAQ:IONS) by our stockscreener. A breakout pattern is formed when a stock consolidates after a strong rise up. We note that this pattern is detected purely based on technical analysis and whether the breakout actually materializes remains to be seen. It could be interesting to keep an eye on NASDAQ:IONS.

IONS Daily chart on 2023-12-19

In-Depth Technical Analysis of NASDAQ:IONS

ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.

Overall IONS gets a technical rating of 9 out of 10. Both in the recent history as in the last year, IONS has proven to be a steady performer, scoring decent points in every aspect analyzed.

  • The long and short term trends are both positive. This is looking good!
  • When comparing the yearly performance of all stocks, we notice that IONS is one of the better performing stocks in the market, outperforming 86% of all stocks.
  • IONS is part of the Biotechnology industry. There are 608 other stocks in this industry. IONS outperforms 79% of them.
  • IONS is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
  • In the last month IONS has a been trading in the 47.93 - 51.89 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.

For an up to date full technical analysis you can check the technical report of IONS

How does the Setup look for NASDAQ:IONS

Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NASDAQ:IONS is 9:

IONS has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is very little resistance above the current price. There is a support zone below the current price at 49.88, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for IONS in the last couple of days, which is a good sign.

How to trade NASDAQ:IONS?

One way to play this would be to wait for the actual breakout to happen and buy when the stock breaks out above the current consolidation zone. A possible place for a stop loss would be below this zone.

Of course, there are many ways to trade or not trade NASDAQ:IONS and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.

More breakout setups can be found in our Breakout screener.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

IONIS PHARMACEUTICALS INC

NASDAQ:IONS (4/22/2024, 1:42:59 PM)

41.64

+0.96 (+2.36%)

IONS News

News Image21 days ago - Ionis Pharmaceuticals, Inc.Ionis to present at upcoming investor conferences

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor...

News Image25 days ago - Ionis Pharmaceuticals, Inc.Ionis to hold olezarsen Phase 3 data webcast

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, April 8th at 10:00 a.m. Eastern Time to...

News Imagea month ago - Ionis Pharmaceuticals, Inc.Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will present positive Phase 3 Balance results in patients with familial...

News Imagea month ago - Market News VideoIonis Pharmaceuticals Enters Oversold Territory (IONS)
News Imagea month ago - Ionis Pharmaceuticals, Inc.Ionis announces positive results from Phase 2 study of ION224, an investigational medicine demonstrating clinical efficacy in the treatment of NASH/MASH

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced positive results from a Phase 2 study of ION224, an investigational DGAT2 antisense...

News Image2 months ago - Biogen Inc.New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
News Image2 months ago - Ionis Pharmaceuticals, Inc.Ionis announces new chief global product strategy officer to lead next phase of commercial growth

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that Kyle Jenne has rejoined Ionis as executive vice president, chief global product...

News Image2 months ago - Ionis Pharmaceuticals, Inc.Ionis to present at upcoming investor conferences

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor...

News Image2 months ago - Market News VideoBullish Two Hundred Day Moving Average Cross - IONS
News Image2 months ago - Seeking AlphaIonis Pharmaceuticals GAAP EPS of -$0.06 beats by $0.80, revenue of $325M beats by $154.1M (NASDAQ:IONS)

Ionis Pharmaceuticals reported strong financial results for Q4 2023, with revenues exceeding expectations and a significant increase compared to the...

News Image2 months ago - Ionis Pharmaceuticals, Inc.Ionis reports fourth quarter and full year 2023 financial results

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (the "Company"), today reported financial results for the fourth quarter and full year ended...

News Image2 months ago - Market News VideoFirst Week of IONS October 18th Options Trading
IONS Links
Follow us for more